Researchers Seek Ways to Minimize Off-Target Effects
Literature Review: Dials for Cas9
Methods to Control Cas9-Based Technologies Across Numerous Dimensions Is Still Lacking
Opening Up Relieves Downstream Bottlenecks
Celebrate the Downstream Improvements That Have Been Achieved, Even If They Fail to Match Upstream Improvements
Top 10 European Biopharma Clusters
The Continent’s Key Academic and Industrial Centers for Drug Development
Search Results for
Cluster's Mass. Appeal Draws Companies, Jobs
August 16, 2016
Takeda said July 29 it will establish one of two global research hubs in Boston/... Takeda will expand a regional presence that includes its Vaccine Business Unit and Takeda ...
Top Eight Asia Biopharma Clusters 2016
May 30, 2016
... For years, biopharma activity in Japan was dominated by heritage pharmaceutical giants led by Takeda and Astellas, as well as academic and other research institutions. But in ...
Top 10 U.S. Biopharma Clusters
May 2, 2016
... Abbott, Baxter International, and their respective spinouts AbbVie and Baxalta, anchor the region, as do the U.S. headquarters of both Astellas and Takeda. #9. Los Angeles / Orange ...
15 Top-Selling Drugs Launched in 2015
March 7, 2016
The eight were Praluent® (Sanofi/Regeneron), Afrezza® (MannKind and, until January, Sanofi), Aristada(tm) (Alkermes), Ninlaro® (Millennium: The Takeda Oncology Company), ...
Takeda, Mersana Expand ADC Collaboration
February 3, 2016
GEN News Highlights More » February 3, 2016 Takeda, Mersana Expand ADC Collaboration Mersana Therapeutics has granted Takeda Pharmaceutical rights to its lead product candidate, ...
Takeda, enGene Collaborate on Gene Pill
January 12, 2016
GEN News Highlights More » January 12, 2016 Takeda, enGene Collaborate on Gene Pill In a strategic alliance announced today, Takeda Pharmaceutical and enGene will begin work on a ...
AstraZeneca Takes Majority Stake in Acerta for $4B
December 17, 2015
GEN News Highlights More » December 17, 2015 AstraZeneca Takes Majority Stake in Acerta for $4B AstraZeneca announced today it will acquire a majority stake in Acerta for $4 ...
Takeda to Sell Its Respiratory Portfolio to AstraZeneca
December 16, 2015
More » December 16, 2015 Takeda to Sell Its Respiratory Portfolio to AstraZeneca In order to concentrate its attention on just four key therapeutic areas, Takeda Pharmaceutical ...
U.S. Hot Spots for Biotech Jobs
November 30, 2015
... Chicago Long known for Astellas and Takeda and other pharma anchors, the region has made moves over the past year to build a bench of startups. Biopharmas are among the 117 ...
14 Industry-Venture Alliances, 2015 Edition
September 14, 2015
... Bay Capital + participating pharmas: Bayer HealthCare, J&J Innovation, Roche, and Takeda Pharmaceuticals USA9 Investment size: Not disclosed Purpose: Identify, fund and ...